{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:01:15Z","timestamp":1781686875430,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900877"],"award-info":[{"award-number":["31900877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10102001"],"award-info":[{"award-number":["2018ZX10102001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.antiviral.2026.106367","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:12:24Z","timestamp":1771258344000},"page":"106367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The potential of leritrelvir repositioning for the treatment of coxsackievirus B4 and common enterovirus infections"],"prefix":"10.1016","volume":"248","author":[{"given":"Qian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuncong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9761-6677","authenticated-orcid":false,"given":"Xingui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-9158","authenticated-orcid":false,"given":"Wenkuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106367_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ajic.2022.12.005","article-title":"Transmission route of rhinovirus - the causative agent for common cold. A systematic review","volume":"51","author":"Andrup","year":"2023","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.antiviral.2026.106367_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.micres.2018.03.008","article-title":"Inhibition of coxsackievirus B4 by Lactobacillus plantarum","volume":"210","author":"Arena","year":"2018","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106367_bib4","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1473-3099(23)00505-4","article-title":"Use of inactivated poliovirus vaccine for poliovirus outbreak response","volume":"24","author":"Bandyopadhyay","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106367_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2018.10.002","article-title":"Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo","volume":"159","author":"Benkahla","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.49.2.619-626.2005","article-title":"Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor","volume":"49","author":"Binford","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106367_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/neup.12121","article-title":"Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins","volume":"34","author":"Bissel","year":"2014","journal-title":"Neuropathology : official journal of the Japanese Society of Neuropathology"},{"key":"10.1016\/j.antiviral.2026.106367_bib8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41564-024-01618-9","article-title":"Preclinical evaluation of the SARS-CoV-2 M(pro) inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir","volume":"9","author":"Chen","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106367_bib9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2261560","article-title":"Severe pneumonia and pathogenic damage in human airway epithelium caused by Coxsackievirus B4","volume":"12","author":"Dai","year":"2023","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2026.106367_bib11","first-page":"52","article-title":"Murine model of acute myocarditis and cerebral cortical neuron edema induced by coxsackievirus B4","volume":"39","author":"Dong","year":"2018","journal-title":"Zool. Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2017.03.010","article-title":"Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro","volume":"50","author":"El Kfoury","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2026.106367_bib13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106367_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/med.2610110103","article-title":"Fluoxetine, a selective inhibitor of serotonin uptake","volume":"11","author":"Fuller","year":"1991","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2026.106367_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/fmb.15.5","article-title":"Coxsackievirus B3 replication and pathogenesis","volume":"10","author":"Garmaroudi","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2026.106367_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/v15040878","article-title":"Viral Protein VP1 Virus-like Particles (VLP) of CVB4 induces protective immunity against lethal challenges with diabetogenic E2 and wild type JBV strains in Mice model","volume":"15","author":"Gharbi","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106367_bib17","first-page":"1985","article-title":"Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance","volume":"149","author":"Hindersson","year":"2004","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib18","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1128\/JVI.01808-12","article-title":"Complete genome sequence of a recombinant coxsackievirus B4 from a patient with a fatal case of hand, foot, and mouth disease in Guangxi, China","volume":"86","author":"Hu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.pmbts.2024.03.033","article-title":"Drug repurposing for respiratory infections","volume":"207","author":"Israr","year":"2024","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.antiviral.2026.106367_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1107\/S2053230X24006915","article-title":"Crystal structures of the 3C proteases from Coxsackievirus B3 and B4","volume":"80","author":"Jiang","year":"2024","journal-title":"Acta Crystallogr. F"},{"key":"10.1016\/j.antiviral.2026.106367_bib21","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.bmcl.2016.05.066","article-title":"Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease","volume":"26","author":"Kawatkar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2026.106367_bib22","first-page":"1","article-title":"Enterovirus surveillance--United States, 1970-2005","volume":"55","author":"Khetsuriani","year":"2006","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.antiviral.2026.106367_bib23","first-page":"1","article-title":"Enterovirus surveillance--United States, 1970-2005","volume":"55","author":"Khetsuriani","year":"2006","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.antiviral.2026.106367_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1423-0127-16-103","article-title":"Viral and host proteins involved in picornavirus life cycle","volume":"16","author":"Lin","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2026.106367_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12929-023-00987-3","article-title":"A novel mucosal bivalent vaccine of EV-A71\/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge","volume":"30","author":"Lin","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2026.106367_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70433","article-title":"Construction and in vitro and in vivo analysis of coxsackievirus B4 reporter viruses: attenuated virulence but highly efficient for antiviral drug screening and evaluation","volume":"97","author":"Liu","year":"2025","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib27","article-title":"Epidemiology of acute respiratory infections in children in guangzhou: a three-year study","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106367_bib28","article-title":"Coxsackievirus B: the important agent of hand, foot, and mouth disease","volume":"95","author":"Liu","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib29","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib30","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.3390\/molecules181011842","article-title":"In vitro and in vivo studies of the inhibitory effects of emodin isolated from Polygonum cuspidatum on Coxsakievirus B4","volume":"18","author":"Liu","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2026.106367_bib31","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.00787-11","article-title":"Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design","volume":"85","author":"Lu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16: epidemiology, diagnosis, and vaccine","volume":"10","author":"Mao","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2026.106367_bib33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1099\/0022-1317-81-3-803","article-title":"Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1\/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes","volume":"81","author":"Mulders","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","article-title":"Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus","volume":"18","author":"Nekoua","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.antiviral.2026.106367_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00018-019-03168-4","article-title":"Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity","volume":"77","author":"Nekoua","year":"2020","journal-title":"Cell. Mol. Life Sci. : CM"},{"key":"10.1016\/j.antiviral.2026.106367_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9061125","article-title":"Persistence of Coxsackievirus B4 in pancreatic \u03b2 cells disturbs insulin maturation, pattern of cellular proteins, and DNA methylation","volume":"9","author":"Nekoua","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.antiviral.2026.106367_bib37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/00007611-198510000-00028","article-title":"Fatal coxsackievirus B4 infection in a neonate","volume":"78","author":"Porres","year":"1985","journal-title":"South. Med. J."},{"key":"10.1016\/j.antiviral.2026.106367_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29010225","article-title":"Computer-Aided prediction of the interactions of viral proteases with antiviral drugs: antiviral potential of broad-spectrum drugs","volume":"29","author":"Ren","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2026.106367_bib39","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/cid\/ciu169","article-title":"Treatment of persistent rhinovirus infection with pegylated interferon alpha2a and ribavirin in patients with hypogammaglobulinemia","volume":"58","author":"Ruuskanen","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106367_bib40","doi-asserted-by":"crossref","first-page":"eaaz2433","DOI":"10.1126\/sciadv.aaz2433","article-title":"A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates","volume":"6","author":"Stone","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.antiviral.2026.106367_bib41","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"Tamura","year":"2011","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.antiviral.2026.106367_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106259","article-title":"miR-342-5p targets CTNNBIP1 to promote enterovirus 71 replication","volume":"182","author":"Tang","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.antiviral.2026.106367_bib43","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/AAC.02084-12","article-title":"Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C","volume":"57","author":"Ulferts","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106367_bib44","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1039\/C7NR08704G","article-title":"Mechanical stiffening of human rhinovirus by cavity-filling antiviral drugs","volume":"10","author":"Valbuena","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.antiviral.2026.106367_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102189","article-title":"Antiviral efficacy of RAY1216 monotherapy and combination therapy with ritonavir in patients with COVID-19: a phase 2, single centre, randomised, double-blind, placebo-controlled trial","volume":"63","author":"Wang","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.antiviral.2026.106367_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jare.2023.03.007","article-title":"Advances in anti-EV-A71 drug development research","volume":"56","author":"Wang","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2337665","article-title":"Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles","volume":"13","author":"Wang","year":"2024","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2026.106367_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100298","article-title":"Recent advances in enterovirus A71 infection and antiviral agents","volume":"104","author":"Wei","year":"2024","journal-title":"Lab. Invest."},{"key":"10.1016\/j.antiviral.2026.106367_bib49","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00705-021-05128-5","article-title":"Coxsackievirus B4: an underestimated pathogen associated with a hand, foot, and mouth disease outbreak","volume":"166","author":"Xiao","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/v16071165","article-title":"Epidemiology of Enterovirus genotypes in Association with human diseases","volume":"16","author":"Xie","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106367_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2016.11.008","article-title":"Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model","volume":"137","author":"Xu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac087","article-title":"FitDock: protein-ligand docking by template fitting","volume":"23","author":"Yang","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.antiviral.2026.106367_bib53","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jep.2013.11.049","article-title":"Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication","volume":"151","author":"Yen","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.antiviral.2026.106367_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4155\/fmc-2022-0195","article-title":"Recent advances in anti-coxsackievirus A16 viral drug research","volume":"15","author":"Yuan","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106367_bib55","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1099\/jgv.0.000911","article-title":"ICTV virus taxonomy profile: picornaviridae","volume":"98","author":"Zell","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2026.106367_bib56","article-title":"Umifenovir epigenetically targets the IL-10 pathway in therapy against Coxsackievirus B4 infection","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.antiviral.2026.106367_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2017.02.018","article-title":"Umifenovir effectively inhibits IL-10 dependent persistent Coxsackie B4 virus infection","volume":"141","author":"Zhang","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106367_bib58","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/AAC.00983-12","article-title":"Fluoxetine is a potent inhibitor of coxsackievirus replication","volume":"56","author":"Zuo","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:44:44Z","timestamp":1781685884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"alternative-id":["S0166354226000264"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106367","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of leritrelvir repositioning for the treatment of coxsackievirus B4 and common enterovirus infections","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106367"}}